MRRSE has announced the addition of the “Geriatric Medicines Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023” report to their offering.
Good Stuff Happens in 1:1 Meetings: Why you need them and how to do them well
Geriatric medicines market analysis, development, growth and demand forecast to 2023
1. Geriatric Medicines Market Analysis, Development, Growth
and Demand Forecast to 2023
Report Description
This report on the geriatrics medicines market studies the
current and future prospects of the global market. Geriatrics
is a branch of medicines concerned with clinical, remedial,
2. preventive, and social aspects of illness usually among people
over 65 years of age. In response to the needs and demands
of an aging population, demand for geriatric medicines has
grown rapidly in last few decades. The elderly patients across
the globe face an array of ill health conditions which include
co-morbid complexities such as falls, cerebral ageing, and
syncope among others. According to the Eurostat the number
of people aged 65 tears and above is likely to be 141 million
by 2050 globally which is approximately 17%-30% increase in
specific population group as compared to 2008 geriatric
population. An article published by the Indian Express in
June 2014 stated that people aged 60 years and above are
likely to reach 323 million mark by 2050. In 2010
approximately 45-50% of the prescriptions were provided to
3. people aged 60 and above and one in three patients took at
least 5 drugs or more on a daily basis in United States. In
last few decades, geriatric medicines have experienced
substantial growth due to which it has now become a
prominent part of the American medicines. National Institute
on Aging aims to improve health and well-being of older
Americans through research and identification of new clinical
interventions. In general geriatric medicines market can be
segmented in three prominent sub classes’ namely therapeutic
category, condition, and geography.
Read Complete Report @ http://www.mrrse.com/geriatric-
medicine-market
4. This report provides in-depth analysis of the global geriatric
medicines market. The stakeholders for this report include
companies involved in the research and development,
manufacturing and commercialization of geriatric medicines,
suppliers, and new entrants planning to invest in this market.
For providing a snapshot of this market to the stakeholders,
executive summary section is included in this report, which
summarizes the market size, trends, and competition for
different geriatric medicines in the major five regions.
This research study analyzes the market for geriatric medicine
market in terms of revenue (US$ Mn). For the research, 2014
has been considered as the base year, while all forecasts
have been provided from 2015 to 2023. The global geriatric
5. medicine market has been broadly segmented on the basis of
condition (Cardiovascular, Arthritis, Neurological, Cancer,
Osteoporosis, Respiratory and Others), therapeutic category
(Analgesic, Antihypertensive, Statins, Antidiabetic, Proton
Pump Inhibitor, Anticoagulant, Antipsychotic, antidepressant
and others), and geography (North America, Europe, Asia
Pacific, Latin America, and Middle East & Africa).
Get a Free Sample Copy of the Report @
http://www.mrrse.com/sample/1620
The market overview section of this report analyzes market
dynamics such as drivers, restraints, and opportunities that
influence the geriatric medicines market in the current and
6. future scenario. Furthermore, the market attractiveness
analysis and pipeline analysis has been included in market
overview section in order to explain the intensity of
competition in the market. Competitive scenario among the
market players is analyzed through a heat map of major
market players in the competitive landscape section of the
report. All these factors will help the market players to
decide about the business strategies and plans to be incurred
in future for strengthening their position in the global
market.
Major drivers that will positively uplift and boost the demand
and growth for geriatric medicines market include increasing
trend with respect to electric record among physicians which
7. reduces the patient discomfort and helps practitioners having
continuous patient monitoring. Apart from this innovations
related to multiple chronic disease treatment, increasing
collaboration of lay organization and NGOs with professional
group will drive the geriatric medicines market in coming
years. Some of the major restraints to this market include
lack of patient participation in clinical trials leading to
development of vaccines or drugs that are not completely
studied and safe.
This report also includes recommendations section that will
assist new companies in establishing their presence and
market players in expanding their market share in the
geriatric medicines market. The report concludes with the
8. company profile section which includes company overview,
financial overview, product portfolio, business strategies, and
recent developments for market players. Some of the
prominent players in geriatric medicines market include
Abbott Laboratories, Inc., AstraZeneca plc, Boehringer
Ingelheim GmbH, Bristol-Myers Squibb Company, Eli Lilly
and Company, GlaxoSmithKline Plc., Merck & Company Inc.,
Novartis AG, Pfizer, Inc., Sanofi S.A
The global geriatric medicines market is segmented as
follows:
Global Geriatric Medicines Market, by Therapeutic Category
11. Japan
Rest of Asia Pacific
Latin America
Brazil
Rest of LATAM
Middle East and Africa
South Africa
Rest of MEA
About MRRSE
MRRSE stands for Market Research Reports Search Engine,
the largest online catalog of latest market research reports
based on industries, companies, and countries. MRRSE
12. sources thousands of industry reports, market statistics, and
company profiles from trusted entities and makes them
available at a click. Besides well-known private publishers,
the reports featured on MRRSE typically come from national
statistics agencies, investment agencies, leading media houses,
trade unions, governments, and embassies.
Contact US:
Corporate Office
State Tower
90 State Street, Suite 700
